A Phase 1, Open-Label Study to Evaluate the Effect of a Low-Fat Meal and Multiple Doses of Ciprofloxacin on the Pharmacokinetics of Vorasidenib in Healthy Subjects
Condition: Healthy Subjects Interventions: Drug: Vorasidenib 40 mg Oral Tablet; Drug: Ciprofloxacin 500 mg Oral Tablet; Drug: Vorasidenib 10 mg Oral Tablet Sponsors: Servier Bio-Innovation LLC; Institut de Recherches Internationales Servier Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 4, 2023 Category: Research Source Type: clinical trials
Detection of Efflux Pump Genes Mediating Ciprofloxacin Resistance in Staphylococcus Aureus Isolates in Sohag University Hospitals
Condition: Patients withInfections Caused by S.Aureus Like Skin Infections , Chest Infections , Surgical Site Infections , and Urinary Tract Infections Intervention: Diagnostic Test: antibiotic sensitivity Sponsor: Sohag University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2023 Category: Research Source Type: clinical trials
LiveSpo Navax ® Supports the Treatment of Acute Rhinosinusitis and Otitis Media
Condition: Upper Respiratory Tract Infections Interventions: Drug: 0.9% NaCl physiological saline Nasal-spraying; Combination Product: LiveSpo Navax®; Drug: Augmentin 500Mg Tablet; Drug: Acetylcysteine; Drug: Xylometazoline Nasal; Drug: Cefotaxime; Drug: Ciprofloxacin Sponsors: Anabio R&D; Thai Binh University of Medicine and Pharmacy Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 7, 2023 Category: Research Source Type: clinical trials
